Cision PR Newswire, Author at World Lifestyler

No Result

View All Result

WORLD LIFESTYLER

No Result

View All Result

Home Author

Cision PR Newswire

Press Releases

Finnate Listed on PathFin.ai Knowledge Hub under the MAS Pathfinder Programme Following Independent Review and Verification Process

June 7, 2026

Press Releases - Lifestyle

Sportradar Group AG (SRAD) Investors: July 17, 2026, Deadline in Securities Fraud Class Action Lawsuit Filed by Kessler Topaz Meltzer & Check, LLP

June 7, 2026

Press Releases

VolitionRx Announces Pricing of $4.6 Million Public Offering

June 7, 2026

Press Releases - Lifestyle

Novo Nordisk’s CagriSema 2.4 mg / 2.4 mg demonstrated significant reduction in HbA1c and weight across multiple studies in the REIMAGINE program presented at ADA 2026

June 7, 2026

Press Releases - Lifestyle

Once-Weekly CagriSema (Amylin-Semaglutide) Combination Injection More Effective than Standalone Medications

June 7, 2026

Press Releases - Lifestyle

AMGEN PRESENTS NEW DATA ACROSS ITS CARDIOMETABOLIC PORTFOLIO AT AMERICAN DIABETES ASSOCIATION 86TH SCIENTIFIC SESSIONS

June 7, 2026

Press Releases - Lifestyle

Lipid-Lowering Medications Demonstrate Cardiometabolic Benefits in Populations with High-Risk Diabetes

June 7, 2026

Press Releases - Lifestyle

Once-Weekly Drug Demonstrates Promising Dual Benefits in Obesity and Metabolic Health

June 7, 2026

Press Releases - Lifestyle

Head-to-head Study Validates the Clinical Advantage of New-generation Biased GLP-1: Ecnoglutide Delivers 35% Greater Weight Loss than Semaglutide

June 7, 2026

Press Releases - Lifestyle

Bronstein, Gewirtz & Grossman LLC Urges Badger Meter, Inc. Investors to Act: Class Action Filed Alleging Investor Harm

June 7, 2026

Page 758 of 3670 Prev 1 … 757 758 759 … 3,670 Next

No Result

View All Result

Home

Cision PR Newswire

Finnate Listed on PathFin.ai Knowledge Hub under the MAS Pathfinder Programme Following Independent Review and Verification Process

Sportradar Group AG (SRAD) Investors: July 17, 2026, Deadline in Securities Fraud Class Action Lawsuit Filed by Kessler Topaz Meltzer & Check, LLP

VolitionRx Announces Pricing of $4.6 Million Public Offering

Novo Nordisk’s CagriSema 2.4 mg / 2.4 mg demonstrated significant reduction in HbA1c and weight across multiple studies in the REIMAGINE program presented at ADA 2026

Once-Weekly CagriSema (Amylin-Semaglutide) Combination Injection More Effective than Standalone Medications

AMGEN PRESENTS NEW DATA ACROSS ITS CARDIOMETABOLIC PORTFOLIO AT AMERICAN DIABETES ASSOCIATION 86TH SCIENTIFIC SESSIONS

Lipid-Lowering Medications Demonstrate Cardiometabolic Benefits in Populations with High-Risk Diabetes

Once-Weekly Drug Demonstrates Promising Dual Benefits in Obesity and Metabolic Health

Head-to-head Study Validates the Clinical Advantage of New-generation Biased GLP-1: Ecnoglutide Delivers 35% Greater Weight Loss than Semaglutide

Bronstein, Gewirtz & Grossman LLC Urges Badger Meter, Inc. Investors to Act: Class Action Filed Alleging Investor Harm

Recommended

FOUNDER SUES: EXOTIC CAR AUCTION EXECUTIVES ACCUSED OF FABRICATING DOCUMENTS TO SEIZE CONTROL. CASE FILED IN NEW YORK SUPREME COURT

Rex’s in Fort Worth Welcomes Global Soccer Fans With 104 Watch Parties During Summer’s Biggest Tournament

Popular News

Armor Health adds Dr. Syretta James, Chief Behavioral Health Officer, as the Company Continues to Transform Behavioral Healthcare in Corrections Through Innovation, Clinical Excellence, and Compassionate Leadership

Courtyard Dayton Beavercreek Celebrates Successful Renovation with Ribbon-Cutting Ceremony

CHEER TOGETHER IN REAL TIME WITH SPECTRUM TV CONTROL PRO FROM SPECTRUM BUSINESS

Checkers & Rally’s Doubles Down on Value with Unbeatable Meal Deal and Bold Menu Innovations

Canomiks Receives 2026 NutraIngredients-USA Editors’ Award for Industry Initiative of the Year

Connect with us

About & Contact

Explore Content

Legal & Privacy

Tiny Media Brands